Unmasking Mounier-Kuhn Syndrome: When a Rare Condition Mimics Common Lung Diseases
"Learn how this often-misdiagnosed condition can lead to recurrent respiratory issues and bronchiectasis, and why early detection is key."
Imagine a condition so rare, it's often missed, masquerading as a run-of-the-mill lung problem. That's Mounier-Kuhn Syndrome (MKS), a condition characterized by an abnormally large trachea and main bronchi. Radiologically, it manifests by marked dilatation of the trachea and main bronchi and symptomatically early in life with recurrent bronchopulmonary infection and bronchiectasis.
MKS isn't just a curiosity; it's a real challenge for those affected. The hallmark of this syndrome is tracheobronchomegaly, weakening and dilation of the trachea and major bronchi. This structural change can lead to a cascade of respiratory issues, making individuals more susceptible to infections and lung damage.
In this article, we'll delve into a case that highlights the importance of recognizing MKS, particularly when it presents later in life. We'll explore how this rare condition can be mistaken for more common respiratory ailments and discuss the diagnostic steps that can lead to accurate identification and appropriate management.
A Rare, Likely Underrecognized Syndrome
Fewer than 500 cases of Mounier–Kuhn syndrome have been reported worldwide, and the cited sources give incidence estimates ranging from 0.5% to 1.6%. The true number may be higher because people without symptoms are often misdiagnosed or remain undiagnosed. A 2025 study also notes that low clinical awareness can lead to MKS being overlooked on chest CT examinations and to diagnostic delays.
Imaging Helps, but Recognition Can Lag
High-resolution computed tomography (HRCT) is described as the gold-standard diagnostic method for bronchiectasis. For Mounier–Kuhn syndrome, chest CT can reveal marked dilation of the trachea and main bronchi, while the condition’s rarity and unknown etiology complicate recognition. The supplied review describes three anatomical types, but its excerpt gives details only for type 1 and part of type 2, so further classification detail cannot be established from the provided material.
The Case: When Recurrent Infections Hint at Something More
Consider a 68-year-old male, a former smoker with a history of recurrent lung infections, excessive sputum production, fever, and worsening dyspnea. He was hospitalized repeatedly for treatment of recurrent bronchopulmonary infection characterized by excessive sputum production, fever and worsening dyspnea. He was an ex-smoker with 36 pack-year smoking history.
- Significant dilation of the trachea (40mm) and main bronchi (28mm each)
- Fiberoptic bronchoscopy revealed an elliptically shaped, dilated trachea with dynamic airway changes during suctioning and coughing.
A Contemporary Review of MKS
A state-of-the-art narrative review characterizes Mounier–Kuhn syndrome, also called tracheobronchomegaly, as an uncommon disease of the central airways marked by pathological dilation of the trachea and main bronchi. The review reports recurrent respiratory infections, bronchiectasis, and hospitalizations, and describes the condition as causing considerable morbidity and mortality. The same abstract is available through PubMed and ScienceDirect.
Spirometry and CT Findings in Airway Disease
In a study of adult Indigenous Australians with chronic airway diseases, FEV1/FVC was reduced in the CT-abnormality groups: 77% for COPD, 87% for bronchiectasis, and 71% for combined COPD and bronchiectasis, compared with 96% and 98% in the CT-normal group. The study’s conclusion says restrictive spirometric patterns were common and obstructive patterns were associated with COPD, alone or alongside bronchiectasis. Separately, a dynamic CT study reported bronchiectasis in 98 of 198 pulmonary lobars and areas of decreased attenuation in 112 of 198; the supplied material does not establish that these findings are specific to MKS.
What This Means for You
Mounier-Kuhn syndrome, while rare, underscores the importance of considering less common diagnoses in patients with persistent respiratory issues. If you or someone you know experiences recurrent lung infections, especially with known lung conditions, it's crucial to discuss the possibility of MKS with a healthcare provider.
How Airway Changes Drive Complications
An analysis of Mounier–Kuhn syndrome reports that tracheobronchomegaly increases dead space and reduces secretion clearance because coughing is ineffective. It identifies recurrent lower respiratory tract infections and bronchiectasis as the most common complications. Together, these observations describe how impaired airway clearance can accompany the syndrome’s recurrent respiratory problems.
Recognizing Combined Airway Findings
A report in the Medical Journal of Bakırköy describes a case published in volume 20, issue 4, in December 2024: case 2 in “Cases of Multiple Tracheobronchial Diverticulosis Characterized by Recurrent Pneumonia Episodes.” The case demonstrates tracheobronchomegaly with tracheal diverticula and cylindrical bronchiectasis of the right upper lobe. This example highlights the value of describing these co-occurring imaging findings in patients with recurrent pneumonia.
A Rare Cause of Late-Onset Bronchiectasis
A 2018 CHEST report describes Mounier–Kuhn syndrome as a rare disorder characterized radiologically by marked dilation of the trachea and main bronchi. It notes that the syndrome can present early in life with recurrent bronchopulmonary infection and bronchiectasis, while reporting a patient whose bronchiectasis had late onset. The case illustrates that bronchiectasis may be attributed to MKS even when it appears later than the commonly described early presentation.
Early diagnosis can lead to targeted management strategies, such as chest physiotherapy and antibiotics during infections, potentially improving quality of life and preventing further lung damage. In severe cases, tracheal stenting or tracheobronchoplasty may be considered.
Remember, knowledge is power. By increasing awareness of rare conditions like MKS, we can empower individuals to seek appropriate medical care and improve their health outcomes.